Država: Armenija
Jezik: engleski
Izvor: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում
ceftriaxone (ceftriaxone sodium)
Anfarm Hellas S.A.
J01DD04
ceftriaxone (ceftriaxone sodium)
1000mg
powder and solvent for solution for i/m injection
(1) glass vial and solvent in ampoule 3.5ml
Prescription
Registered
2016-10-17
PACKAGE LEAFLET – INFORMATION FOR THE PATIENT MARION POWDER FOR SOLUTION FOR INJECTION OR INFUSION 1G MARION POWDER AND SOLVENT FOR SOLUTION FOR I.M. INJECTION 1G CEFTRIAXONE (AS CEFTRIAXONE SODIUM) PLEASE READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START HAVING THIS MEDICINE. Keep this leaflet. You may need to read it again. If you have any further questions, ask your doctor or nurse. If any of the side effects become serious or troublesome, or if you notice any side effects not listed in this leaflet, please tell your doctor or nurse. IN THIS LEAFLET: 1. What MARION is and what it is used for 2. Before you are given MARION 3. How MARION is given 4. Possible side effects 5. How to store MARION 6. Further information 1. WHAT MARION IS AND WHAT IT IS USED FOR MARION is an antibiotic given to adults and children (including newborn babies). It works by killing bacteria that cause infections. MARION contains a medicine called ceftriaxone. It belongs to a group of medicines called cephalosporins. MARION is used to treat infections of the brain (meningitis). the lungs. the middle ear. the abdomen and abdominal wall (peritonitis). the urinary tract and kidneys. bones and joints. the skin or soft tissues. the blood. the heart. It can be given: to treat specific sexually transmitted infections (gonorrhoea and syphilis). to treat patients with low white blood cell counts (neutropenia) who have fever due to bacterial infection. to treat infections of the chest in adults with chronic bronchitis. to treat Lyme disease (caused by tick bites) in adults and children including newborn babies from 15 days of age. to prevent infections during surgery. 2. BEFORE YOU ARE GIVEN MARION YOU MUST NOT BE GIVEN MARION IF: You are allergic (hypersensitive) to ceftriaxone (the only ingredient in MARION). You are allergic to antibiotics called ‘cephalosporins’. These include cefalexin, cefaclor and cefuroxime. You have had a SUDDEN OR SEVERE allergic react Pročitajte cijeli dokument
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT MARION _ _ Powder and Solvent for solution for I.M. injection 1g MARION _ _ Powder for solution for injection or infusion 1g 2. QUALITATIVE AND QUANTITATIVE COMPOSITION MARION _ _ Powder and Solvent for solution for I.M. injection 1g: Each vial contains ceftriaxone sodium equivalent to ceftriaxone 1g. Each ampoule of solvent contains lidocaine hydrochloride 35mg, water for injection qs 3.5ml MARION Powder for solution for injection or infusion 1g: Each vial contains ceftriaxone sodium equivalent to ceftriaxone 1g 3. PHARMACEUTICAL FORM Powder and solvent for solution for I.M. injection Powder for solution for injection or infusion 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Ceftriaxone is indicated for the treatment of the following infections in adults and children including term neonates (from birth): Bacterial Meningitis Community acquired pneumonia Hospital acquired pneumonia Acute otitis media Intra-abdominal infections Complicated urinary tract infections (including pyelonephritis) Infections of bones and joints Complicated skin and soft tissue infections Gonorrhoea Syphilis Bacterial endocarditis Ceftriaxone may be used: For treatment of acute exacerbations of chronic obstructive pulmonary disease in adults For treatment of disseminated Lyme borreliosis (early (stage II) and late (stage III)) in adults and children including neonates from 15 days of age. For Pre-operative prophylaxis of surgical site infections. In the management of neutropenic patients with fever that is suspected to be due to a bacterial infection. In the treatment of patients with bacteraemia that occurs in association with, or is suspected to be associated with, any of the infections listed above. Treatment may be started before the results of susceptibility tests are known. Ceftriaxone should be co-administered with other antibacterial agents whenever the possible range of causative bacteria would not Pročitajte cijeli dokument